MoneyWorks4Me

Auro Laboratories - Quaterly Results

28 Jan 2022 Evaluate
A decrease in the sales to Rs. 121.37 millions was observed for the quarter ended December 2021. The sales stood at Rs. 131.09 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 6.10 millions for the quarter ended December 2021 a decline of -70.00% from Rs. 20.33 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 12.39 millions from 31.13 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 121.37 131.09 -7.41 329.83 406.88 -18.94 542.52 437.91 23.89
Other Income 0.21 2.50 -91.60 8.10 5.86 38.23 7.58 9.73 -22.10
PBIDT 12.39 31.13 -60.20 45.32 87.93 -48.46 120.00 72.43 65.68
Interest 1.65 0.49 236.73 4.30 2.09 105.74 4.58 5.78 -20.76
PBDT 10.74 30.64 -64.95 41.02 85.84 -52.21 115.42 66.65 73.17
Depreciation 2.60 2.60 0.00 7.80 7.60 2.63 10.36 10.23 1.27
PBT 8.14 28.04 -70.97 33.22 78.24 -57.54 105.06 56.42 86.21
TAX 2.04 7.71 -73.54 9.34 21.52 -56.60 33.26 15.87 109.58
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.25 0.62 101.61
PAT 6.10 20.33 -70.00 23.88 56.72 -57.90 71.80 40.55 77.07
Equity 62.33 62.33 0.00 62.33 62.33 0.00 62.32 62.32 0.00
PBIDTM(%) 10.21 23.75 -57.01 13.74 21.61 -36.42 22.12 16.54 33.73
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..